Seer SEER
Seer reported a $13.74 million net loss for Q3 2026.
Seer (SEER) filed a 10-Q with the SEC on Nov 10, 2026, 4:30 pm ET. Source: the filing on SEC EDGAR.
- Form
- 10-Q
- Filed
- Importance
- Notable
- Accession
- 0001193125-26-455566
- Revenue of $3.98 million for the three months ended Sep 30, 2026.
- Net loss of $13.74 million for the three months ended Sep 30, 2026.
- Cash and equivalents of $29.32 million as of Sep 30, 2026.
Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.
What changed since last quarter
1 new risk factor · 1 new legal mention
Compared with the 10-Q for the period ended Jun 30, 2026.
| This filing | Previous | Change vs prior 10-Q | |
|---|---|---|---|
| Revenue | $3.98M | $3.1M | +28% |
| Operating income and margin | −$14.67M · -368.4% | −$16.84M · -542.9% | +13%, margin +174.5 pts |
| Net income | −$13.74M | −$16.9M | +19% |
| Operating cash flow | −$9.53M | −$9.57M | +0.4% |
| Cash | $29.32M | $26.08M | +12% |
New risk factors (1)
- We have recently experienced changes in our senior management team. Effective October 1, 2026, David Horn resigned as our President and Chief Financial Officer. In connection with Mr. Horn's resignation, Charles Endweiss, our Vice President, Financial Planning & Analysis, was appointed Treasurer and serves as our…
New legal mentions (1)
- For a description of our actions against Nanomics Biotechnology Co., Ltd., see the section titled "Risk Factors—Risks Related to our Intellectual Property" in this Quarterly Report. +1 more paragraph